N
Nicolas Kahn
Researcher at Heidelberg University
Publications - 75
Citations - 2327
Nicolas Kahn is an academic researcher from Heidelberg University. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 15, co-authored 56 publications receiving 1525 citations. Previous affiliations of Nicolas Kahn include University Hospital Heidelberg.
Papers
More filters
Journal ArticleDOI
SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells.
Soeren Lukassen,Robert Lorenz Chua,Timo Trefzer,Nicolas Kahn,Marc A. Schneider,Thomas Muley,Hauke Winter,Michael Meister,Carmen Veith,Agnes W. Boots,Bianca P Hennig,Michael Kreuter,Christian Conrad,Roland Eils,Roland Eils +14 more
TL;DR: This work investigates ACE2 and TMPRSS2 expression levels and their distribution across cell types in lung tissue and in cells derived from subsegmental bronchial branches by single nuclei and single cell RNA sequencing, suggesting increased vulnerability for SARS‐CoV‐2 infection.
Journal ArticleDOI
Combined Endoscopic-Endobronchial Ultrasound-Guided Fine-Needle Aspiration of Mediastinal Lymph Nodes Through a Single Bronchoscope in 150 Patients With Suspected Lung Cancer
TL;DR: The two procedures can easily be performed with a dedicated linear endobronchial ultrasound bronchoscope in one setting and by one operator and provide better diagnostic accuracy than either one alone.
Journal ArticleDOI
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Jürgen Behr,Antje Prasse,Michael Kreuter,Johannes Johow,Klaus F. Rabe,Francesco Bonella,Reiner Bonnet,Christian Grohe,Matthias Held,Heinrike Wilkens,P Hammerl,Dirk Koschel,Stefan Blaas,Hubert Wirtz,Joachim H. Ficker,Wolfgang Neumeister,Nicolas Schönfeld,Martin Claussen,Nikolaus Kneidinger,Marion Frankenberger,Simone Hummler,Nicolas Kahn,Silke Tello,Julia Freise,Tobias Welte,Petra Neuser,Andreas Günther,Nicolaus Schönfeld,Carmen Schade-Brittinger,Behnaz Aminossadati,Christian Nasemann,Soraya Yahiaoui,Christoph Dupuy Backofen,Maik Hahmann,Michael Wittenberg,Fotis Drakopanagiotakis,Daniel von der Beck,Stefanie Ghofrani,Sabine Heinemann,Ekaterina Krauss,Hella Rethorn,Andrea Koch,Gabriela Leuschner,Sandhya Matthes,Claus Neurohr,Tobias Veit,Katrin Milger-Kneidinger,Felix J.F. Herth,Julia Benstz,Thomas Bahmer,Heike Biller,Benjamin Waschki,Rosa-Marie Apel,Ulrich Costabel,Eva Börner,Thomas Wessendorf,Margret Arnrich,Lacramioara Ilie,Alexandra Wald,Hans-Jürgen Seyfarth,Christian Reinhardt,Atif Cinar,Markus Vogler,Siegfried Matthias Huhn,Jaqueline Richter,Ulrich Neff,Torsten Gerriet Blum,Silvan Vesenbeckh,Christian Boch,Hannes Semper,Andreas Wilke,Michael Pfeifer,Annette Schweda,Angelika Krill,Christian Lensch,Franziska Joa,Barbara Schröder,Annabel Plaßmeier,Stefan Baron,Klaus Peter Froehling +79 more
TL;DR: In this paper, the authors evaluated the efficacy and safety of pirfenidone in patients with four non-IPF progressive fibrotic interstitial lung diseases (ILDs), including collagen or vascular diseases (i.e., connective tissue disease-associated ILDs), non-specific interstitial pneumonia, chronic hypersensitivity pneumonitis, or asbestos-induced lung fibrosis.
Journal ArticleDOI
The therapy of idiopathic pulmonary fibrosis: what is next?
Vivien Somogyi,Vivien Somogyi,Nazia Chaudhuri,Sebastiano Emanuele Torrisi,Sebastiano Emanuele Torrisi,Nicolas Kahn,Veronika Müller,Michael Kreuter +7 more
TL;DR: New therapeutic attempts and potential future approaches to treat IPF are summarised to aim to reduce the burden of disease.
Journal ArticleDOI
LungPoint—A New Approach to Peripheral Lesions
Ralf Eberhardt,Nicolas Kahn,Daniela Gompelmann,Maren Schumann,Claus Peter Heussel,Felix J.F. Herth +5 more
TL;DR: A new bronchoscopic navigation system is useful for bronchoscopy for pulmonary peripheral lesions (NCT01067755) and can help access the peripheral lung airways and enable lesion sampling.